Rezolute, Inc.(RZLT)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

RZLT Rezolute, Inc.

交易中 05-07 14:50:29 EDT

3.15

+0.01

+0.16%

最高3.15	最低3.00	成交量54.43万
今开3.13	昨收3.14	日振幅4.77%
总市值3.01亿	流通市值2.28亿	总股本9,570万
成交额166.83万	换手率0.75%	流通股本7,251万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"RZLT","market":"US","secType":"STK","nameCN":"Rezolute, Inc.","latestPrice":3.145,"timestamp":1778179809655,"preClose":3.14,"halted":0,"volume":544309,"delay":0,"changeRate":0.0015923566878980552,"floatShares":72507800,"shares":95697700,"eps":-0.907791,"marketStatus":"交易中","change":0.005,"latestTime":"05-07 14:50:29 EDT","open":3.13,"high":3.15,"low":3.0001,"amount":1668321.4003267,"amplitude":0.047739,"askPrice":3.15,"askSize":200,"bidPrice":3.14,"bidSize":806,"shortable":3,"etf":0,"ttmEps":-0.907791,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1778184000000},"marketStatusCode":2,"adr":0,"exchange":"NASDAQ","adjPreClose":3.14,"preHourTrading":{"tag":"盘前","latestPrice":3.124,"preClose":3.14,"latestTime":"09:18 EDT","volume":2862,"amount":8991.503901,"timestamp":1778159891011,"change":-0.016,"changeRate":-0.005096,"amplitude":0.031847},"postHourTrading":{"tag":"盘后","latestPrice":3.18,"preClose":3.14,"latestTime":"19:53 EDT","volume":11427,"amount":36024.469,"timestamp":1778111625871,"change":0.04,"changeRate":0.012739,"amplitude":0.025478},"volumeRatio":0.48034,"impliedVol":2.0032,"impliedVolPercentile":0.7331},"requestUrl":"/m/hq/s/RZLT","defaultTab":"news","newsList":[{"id":"1143041487","title":"Rezolute公布Ersodetug治疗先天性高胰岛素血症三期Sunrize研究结果，将在儿科内分泌学会年会进行口头报告","url":"https://stock-news.laohu8.com/highlight/detail?id=1143041487","media":"美股速递","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1143041487?lang=zh_cn&edition=full","pubTime":"2026-05-02 00:15","pubTimestamp":1777652113,"startTime":"0","endTime":"0","summary":"Rezolute公司宣布，其针对先天性高胰岛素血症患者的三期Sunrize临床试验中Ersodetug的研究成果，将于儿科内分泌学会年度会议上以口头报告形式呈现。这项重要研究数据的披露，标志着公司在罕见病治疗领域取得的关键进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118664572","title":"Rezolute公司：FDA鼓励其提交研究报告及分析数据集以供机构独立评估","url":"https://stock-news.laohu8.com/highlight/detail?id=1118664572","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1118664572?lang=zh_cn&edition=full","pubTime":"2026-03-24 19:04","pubTimestamp":1774350296,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局（FDA）已鼓励Rezolute, Inc.提交相关研究报告与分析数据集，以便该监管机构能够进行独立的评估审查。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1114394907","title":"Rezolute, Inc.：FDA承认先天性高胰岛素血症试验中行为因素与SMBG局限性的挑战","url":"https://stock-news.laohu8.com/highlight/detail?id=1114394907","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1114394907?lang=zh_cn&edition=full","pubTime":"2026-03-24 19:03","pubTimestamp":1774350234,"startTime":"0","endTime":"0","summary":"美国食品药品监督管理局近期指出，在针对先天性高胰岛素血症的临床试验中，行为因素与自我血糖监测技术的局限性构成了显著挑战。这一表态凸显了在该疾病领域开发有效疗法的复杂性。对于专注于罕见病疗法研发的Rezolute, Inc.而言，FDA的这一认知可能为其相关临床试验方案的设计与优化提供重要参考。公司或需在试验中纳入更全面的行为评估体系，并探索动态血糖监测等替代方案，以提升数据质量。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140002857","title":"Rezolute公布先天性高胰岛素血症三期Sunrize研究进展 并分享肿瘤性高胰岛素血症扩大可及性计划发现","url":"https://stock-news.laohu8.com/highlight/detail?id=1140002857","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140002857?lang=zh_cn&edition=full","pubTime":"2026-01-07 20:14","pubTimestamp":1767788057,"startTime":"0","endTime":"0","summary":"生物制药公司Rezolute, Inc.近日披露了其针对先天性高胰岛素血症的三期临床试验Sunrize研究的最新分析结果，同时公布了肿瘤相关高胰岛素血症扩大可及性计划的临床观察数据。该研究旨在评估创新疗法对罕见代谢疾病的治疗效果，而扩展访问项目则为急需治疗的患者提供了早期用药机会。初步数据显示，实验性药物在控制血糖波动和减少低血糖事件方面表现出潜在临床价值。研究人员指出，这些发现将为后续治疗方案优化提供重要参考，同时有助于加速罕见病治疗领域的研发进程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1166602535","title":"Rezolute高管表示，因严重过敏反应而停药的两名患者未检测到阳性抗药物抗体 - 电话会议","url":"https://stock-news.laohu8.com/highlight/detail?id=1166602535","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1166602535?lang=zh_cn&edition=full","pubTime":"2025-12-11 22:11","pubTimestamp":1765462283,"startTime":"0","endTime":"0","summary":"Rezolute高管表示，因严重过敏反应而停药的两名患者未检测到阳性抗药物抗体 - 电话会议","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1136341643","title":"Rezolute高管表示，63名参与者中有四名因不良事件早期终止研究","url":"https://stock-news.laohu8.com/highlight/detail?id=1136341643","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1136341643?lang=zh_cn&edition=full","pubTime":"2025-12-11 21:54","pubTimestamp":1765461255,"startTime":"0","endTime":"0","summary":"Rezolute高管表示，63名参与者中有四名患者因不良事件早期终止了研究。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1181940294","title":"Rezolute股价在盘前暴跌91.3%，原因是罕见疾病药物在晚期研究中未能达到主要目标","url":"https://stock-news.laohu8.com/highlight/detail?id=1181940294","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1181940294?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:47","pubTimestamp":1765457249,"startTime":"0","endTime":"0","summary":"Rezolute股价在盘前暴跌91.3%，原因是罕见疾病药物在晚期研究中未能达到主要目标","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188653278","title":"Rezolute, Inc.：肿瘤Hi的第三阶段Uplift研究正在进行中，预计2026年下半年发布初步结果","url":"https://stock-news.laohu8.com/highlight/detail?id=1188653278","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1188653278?lang=zh_cn&edition=full","pubTime":"2025-12-11 20:02","pubTimestamp":1765454576,"startTime":"0","endTime":"0","summary":"Rezolute, Inc.：肿瘤Hi的第三阶段Uplift研究正在进行中，预计2026年下半年发布初步结果","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2585660165","title":"Rezolute, Inc.盘中异动 临近收盘大幅跳水5.02%报9.65美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2585660165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2585660165?lang=zh_cn&edition=full","pubTime":"2025-11-21 04:55","pubTimestamp":1763672150,"startTime":"0","endTime":"0","summary":"北京时间2025年11月21日04时55分，Rezolute, Inc.股票出现异动，股价快速下挫5.02%。截至发稿，该股报9.65美元/股，成交量81.8487万股，换手率0.88%，振幅9.60%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为0.40%。Rezolute, Inc.公司简介：Rezolute Inc是一家临床阶段的生物制药公司，专注于开发罕见和代谢性疾病的疗法。Rezolute的管线包括旨在改善患者预后并减轻治疗负担的候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121045551977630c8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251121045551977630c8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108788621","title":"Rezolute 第一季度每股收益 USD -0.18","url":"https://stock-news.laohu8.com/highlight/detail?id=1108788621","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1108788621?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:02","pubTimestamp":1763571779,"startTime":"0","endTime":"0","summary":"11月06日 - Rezolute 第一季度运营费用为1981.7万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2518628274","title":"Rezolute, Inc.盘中异动 快速下挫5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518628274","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518628274?lang=zh_cn&edition=full","pubTime":"2025-03-10 21:57","pubTimestamp":1741615067,"startTime":"0","endTime":"0","summary":"北京时间2025年03月10日21时57分，Rezolute, Inc.股票出现波动，股价急速下挫5.45%。截至发稿，该股报3.64美元/股，成交量3.7545万股，换手率0.06%，振幅3.38%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Checkpoint Therapeutics, Inc.、Trevi Therapeutics, Inc.、Mineralys Therapeutics, Inc.涨幅较大，Biodexa Pharmaceuticals Plc、Scisparc Ltd.、Dogwood Therapeutics, Inc.较为活跃，换手率分别为2983.67%、650.72%、233.81%，振幅较大的相关个股有Dogwood Therapeutics, Inc.、Scisparc Ltd.、Impact Biomedical, Inc.，振幅分别为41.36%、40.24%、28.59%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021574798a2a3dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025031021574798a2a3dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516366838","title":"Rezolute, Inc.盘中异动 下午盘股价大跌5.08%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516366838","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516366838?lang=zh_cn&edition=full","pubTime":"2025-03-04 03:48","pubTimestamp":1741031325,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日03时48分，Rezolute, Inc.股票出现波动，股价大幅跳水5.08%。截至发稿，该股报4.21美元/股，成交量22.0311万股，换手率0.36%，振幅5.53%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为0.70%。其相关个股中，Bioxcel Therapeutics, Inc.、Abpro Holdings Inc C/Wts 12/11/2029 、Biocardia, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Allarity Therapeutics, Inc.、Entero Therapeutics Inc.较为活跃，换手率分别为4563.20%、208.83%、182.02%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Radiopharm Theranostics Limited、Entero Therapeutics Inc.，振幅分别为206.20%、119.50%、70.53%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304034845a25d97c2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304034845a25d97c2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516372678","title":"Rezolute, Inc.盘中异动 股价大涨5.42%","url":"https://stock-news.laohu8.com/highlight/detail?id=2516372678","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516372678?lang=zh_cn&edition=full","pubTime":"2025-03-01 01:13","pubTimestamp":1740762828,"startTime":"0","endTime":"0","summary":"北京时间2025年03月01日01时13分，Rezolute, Inc.股票出现异动，股价急速拉升5.42%。截至发稿，该股报4.47美元/股，成交量9.8222万股，换手率0.16%，振幅6.13%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为0.57%。其相关个股中，Bioxcel Therapeutics, Inc.、Camp4 Therapeutics Corporation、Enveric Biosciences, Inc.涨幅较大，Bioxcel Therapeutics, Inc.、Enveric Biosciences, Inc.、Virpax Pharmaceuticals, Inc.较为活跃，换手率分别为3080.88%、502.73%、371.83%，振幅较大的相关个股有Bioxcel Therapeutics, Inc.、Cardio Diagnostics Holdings Inc C/Wts  To Pur Com、Nrx Pharmaceuticals Inc C/Wts 24/05/2026 ，振幅分别为57.80%、49.50%、48.19%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301011349a258291f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250301011349a258291f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514337363","title":"Rezolute, Inc.盘中异动 临近收盘急速下跌5.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514337363","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514337363?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:43","pubTimestamp":1740689007,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时43分，Rezolute, Inc.股票出现波动，股价大幅下跌5.16%。截至发稿，该股报4.23美元/股，成交量23.3931万股，换手率0.39%，振幅6.37%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为0.48%。其相关个股中，Pepgen Inc.、Ibio, Inc.、Cingulate Inc C/Wts 10/12/2026 涨幅较大，Quoin Pharmaceuticals Ltd、Aeon Biopharma, Inc.、Vincerx Pharma, Inc.较为活跃，换手率分别为1943.10%、410.31%、197.19%，振幅较大的相关个股有Neurosense Therapeutics Ltd C/Wts 10/11/2026 、Pepgen Inc.、Pds Biotechnology Corporation，振幅分别为86.14%、67.32%、55.84%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044328989553ce&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228044328989553ce&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514011085","title":"Rezolute, Inc.盘中异动 股价大跌5.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514011085","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514011085?lang=zh_cn&edition=full","pubTime":"2025-02-26 00:40","pubTimestamp":1740501603,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日00时40分，Rezolute, Inc.股票出现异动，股价快速跳水5.06%。截至发稿，该股报4.11美元/股，成交量15.8795万股，换手率0.26%，振幅5.18%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为0.02%。其相关个股中，Abpro Holdings Inc C/Wts 12/11/2029 、Silexion Therapeutics Corp、Conduit Pharmaceuticals Inc C/Wts 22/09/2028涨幅较大，Gt Biopharma, Inc.、Silexion Therapeutics Corp、Moleculin Biotech, Inc.较为活跃，换手率分别为1117.61%、925.41%、694.53%，振幅较大的相关个股有Silexion Therapeutics Corp、Abpro Holdings Inc C/Wts 12/11/2029 、Adial Pharmaceuticals, Inc，振幅分别为87.83%、66.67%、64.05%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600400496300e10&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025022600400496300e10&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513720950","title":"Rezolute, Inc.盘中异动 股价大跌5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513720950","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513720950?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:03","pubTimestamp":1740409437,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时03分，Rezolute, Inc.股票出现波动，股价急速下跌5.45%。截至发稿，该股报4.28美元/股，成交量3.0731万股，换手率0.05%，振幅5.57%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为0.34%。其相关个股中，Pepgen Inc.、Avalo Therapeutics, Inc.、Telix Pharmaceutic涨幅较大，Pepgen Inc.、Aditxt, Inc.、Biodexa Pharmaceuticals Plc较为活跃，换手率分别为158.08%、70.49%、25.66%，振幅较大的相关个股有Pepgen Inc.、Telix Pharmaceutic、Aspire Biopharma Holdings Inc C/Wts 14/02/2030 ，振幅分别为137.23%、55.69%、42.86%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242303579890fde2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242303579890fde2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1104122226","title":"Rezolute第二季度每股收益$(0.22)优于$(0.25)的预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1104122226","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1104122226?lang=zh_cn&edition=full","pubTime":"2025-02-13 05:35","pubTimestamp":1739396117,"startTime":"0","endTime":"0","summary":"Rezolute公布的季度每股亏损为$，较分析师一致预期的$每股亏损高出12%。相比去年同期每股亏损$，此次数据提高了18.52%。以上内容来自Benzinga Earnings专栏，原文如下：Rezolute  reported quarterly losses of $ per share which beat the analyst consensus estimate of $ by 12 percent. This is a 18.52 percent increase over losses of $ per share from the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Rezolute第二季度每股收益$(0.22)优于$(0.25)的预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2509041742","title":"Rezolute, Inc.盘中异动 股价大跌5.21%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509041742","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509041742?lang=zh_cn&edition=full","pubTime":"2025-02-07 01:41","pubTimestamp":1738863683,"startTime":"0","endTime":"0","summary":"北京时间2025年02月07日01时41分，Rezolute, Inc.股票出现异动，股价急速下挫5.21%。截至发稿，该股报5.28美元/股，成交量14.0952万股，换手率0.24%，振幅5.57%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为0.12%。其相关个股中，Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Geovax Labs Inc C/Wts 29/09/2025涨幅较大，Lipella Pharmaceuticals Inc.、Transcode Therapeutics, Inc.、Azitra Inc较为活跃，换手率分别为6347.62%、1647.86%、165.56%，振幅较大的相关个股有Lipella Pharmaceuticals Inc.、Palatin Technologies, Inc.、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为125.58%、58.78%、53.02%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207014123a23bf601&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250207014123a23bf601&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508846881","title":"Rezolute, Inc.盘中异动 快速下跌5.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508846881","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508846881?lang=zh_cn&edition=full","pubTime":"2025-02-04 22:56","pubTimestamp":1738681017,"startTime":"0","endTime":"0","summary":"北京时间2025年02月04日22时56分，Rezolute, Inc.股票出现波动，股价快速下挫5.53%。截至发稿，该股报4.95美元/股，成交量7.6437万股，换手率0.13%，振幅5.34%。Rezolute, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。其相关个股中，Azitra Inc、Evaxion Biotech As、Regulus Therapeutics Inc.涨幅较大，Azitra Inc、Evaxion Biotech As、Enveric Biosciences, Inc.较为活跃，换手率分别为1328.16%、829.05%、206.35%，振幅较大的相关个股有Azitra Inc、Briacell Therapeutics Corp C/Wts 24/02/2025、Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 ，振幅分别为49.48%、40.00%、39.00%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225657a2392e37&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250204225657a2392e37&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","RZLT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2508149063","title":"Rezolute, Inc.盘中异动 急速下挫5.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508149063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508149063?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:44","pubTimestamp":1738593849,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时44分，Rezolute, Inc.股票出现波动，股价急速下跌5.11%。截至发稿，该股报4.98美元/股，成交量3.8621万股，换手率0.07%，振幅5.33%。Rezolute, Inc.股票所在的生物技术行业中，整体跌幅为0.27%。其相关个股中，Hcw Biologics Inc.、Gh Research Plc、Invivyd, Inc.涨幅较大，Hcw Biologics Inc.、Briacell Therapeutics Corp.、Cyclerion Therapeutics, Inc.较为活跃，换手率分别为402.40%、343.06%、184.54%，振幅较大的相关个股有Hcw Biologics Inc.、Psyence Biomedical Ltd C/Wts 25/01/2029、Invivyd, Inc.，振幅分别为82.67%、50.76%、35.62%。Rezolute, Inc.公司简介：Rezolute Inc 是一家生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224409abc10a44&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250203224409abc10a44&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["RZLT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.rezolutebio.com","stockEarnings":[{"period":"1week","weight":0.0064},{"period":"1month","weight":-0.0368},{"period":"3month","weight":0.0753},{"period":"6month","weight":-0.7082},{"period":"1year","weight":-0.1649},{"period":"ytd","weight":0.3305}],"compareEarnings":[{"period":"1week","weight":0.0313},{"period":"1month","weight":0.1137},{"period":"3month","weight":0.083},{"period":"6month","weight":0.0937},{"period":"1year","weight":0.3132},{"period":"ytd","weight":0.0761}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Rezolute, Inc.于2010年在特拉华州注册成立，并于2021年6月在内华达州重新注册成立。该公司是一家晚期罕见病公司，专注于显著改善由高胰岛素血症（“HI”）引起的低血糖患者的预后。该公司的主要临床资产ersodetug是一种潜在的治疗多种形式的高胰岛素血症引起的低血糖。","yearOnYearQuotes":[{"month":1,"riseRate":0.875,"avgChangeRate":0.374728},{"month":2,"riseRate":0.25,"avgChangeRate":-0.065721},{"month":3,"riseRate":0.25,"avgChangeRate":-0.091782},{"month":4,"riseRate":0.75,"avgChangeRate":0.064438},{"month":5,"riseRate":0.444444,"avgChangeRate":0.045487},{"month":6,"riseRate":0.75,"avgChangeRate":0.163559},{"month":7,"riseRate":0.5,"avgChangeRate":0.338882},{"month":8,"riseRate":0.5,"avgChangeRate":-0.011128},{"month":9,"riseRate":0.375,"avgChangeRate":-0.025618},{"month":10,"riseRate":0.25,"avgChangeRate":-0.158563},{"month":11,"riseRate":0.25,"avgChangeRate":0.027082},{"month":12,"riseRate":0.25,"avgChangeRate":-0.199901}],"exchange":"NASDAQ","name":"Rezolute, Inc.","nameEN":"Rezolute, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.1","shortVersion":"4.42.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Rezolute, Inc.(RZLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Rezolute, Inc.(RZLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Rezolute, Inc.,RZLT,Rezolute, Inc.股票,Rezolute, Inc.股票老虎,Rezolute, Inc.股票老虎国际,Rezolute, Inc.行情,Rezolute, Inc.股票行情,Rezolute, Inc.股价,Rezolute, Inc.股市,Rezolute, Inc.股票价格,Rezolute, Inc.股票交易,Rezolute, Inc.股票购买,Rezolute, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Rezolute, Inc.(RZLT)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Rezolute, Inc.(RZLT)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}